In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as BioSmartLtd has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
KOSDAQ:A038460 - Analysts future estimates and past financials data (KRW Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2026
515,820
11,448
-23,372
14,732
N/A
12/31/2025
482,776
9,009
-9,692
24,073
N/A
9/30/2025
475,031
7,215
18,299
23,946
N/A
6/30/2025
468,606
1,724
19,570
26,999
N/A
3/31/2025
477,902
-2,208
-2,889
5,563
N/A
12/31/2024
484,310
127
-4,953
3,708
N/A
9/30/2024
477,337
7,128
-16,331
-8,214
N/A
6/30/2024
472,310
8,960
-18,776
-12,594
N/A
3/31/2024
464,377
19,482
-1,012
2,976
N/A
12/31/2023
456,164
17,907
-3,752
1,166
N/A
9/30/2023
451,693
4,464
5,368
10,608
N/A
6/30/2023
430,618
6,121
2,172
7,011
N/A
3/31/2023
409,344
2,038
2,754
9,223
N/A
12/31/2022
391,822
721
422
6,289
N/A
9/30/2022
332,856
2,354
-8,714
-2,967
N/A
6/30/2022
287,736
1,084
-12,995
-7,156
N/A
3/31/2022
237,788
2,909
-12,109
-7,414
N/A
12/31/2021
189,183
1,392
-4,660
1,203
N/A
9/30/2021
184,940
-5,440
-3,808
1,814
N/A
6/30/2021
175,807
-6,891
-1,921
3,963
N/A
3/31/2021
167,868
-9,990
-9,880
-608
N/A
12/31/2020
166,429
-8,737
-16,739
-7,487
N/A
9/30/2020
166,395
3,247
-18,008
-7,133
N/A
6/30/2020
167,212
19,930
-21,227
-9,438
N/A
3/31/2020
165,732
20,842
-15,986
-6,500
N/A
12/31/2019
158,968
22,147
N/A
-1,836
N/A
9/30/2019
151,426
18,046
N/A
1,662
N/A
6/30/2019
143,927
4,646
N/A
4,640
N/A
3/31/2019
129,529
6,744
N/A
5,374
N/A
12/31/2018
117,733
5,135
N/A
5,813
N/A
9/30/2018
103,108
8,645
N/A
5,675
N/A
6/30/2018
92,498
7,691
N/A
4,417
N/A
3/31/2018
87,489
5,585
N/A
140
N/A
12/31/2017
80,433
4,826
N/A
-1,757
N/A
9/30/2017
79,513
2,594
N/A
-3,726
N/A
6/30/2017
74,780
1,697
N/A
-6,520
N/A
3/31/2017
68,027
495
N/A
-4,954
N/A
12/31/2016
62,990
619
N/A
-3,127
N/A
9/30/2016
58,815
1,619
N/A
-2,846
N/A
6/30/2016
55,946
2,134
N/A
-53
N/A
3/31/2016
55,204
1,619
N/A
129
N/A
12/31/2015
54,187
3,148
N/A
-509
N/A
9/30/2015
50,636
2,178
N/A
-1,858
N/A
6/30/2015
46,468
650
N/A
-1,322
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A038460's forecast earnings growth is above the savings rate (3.1%).
Earnings vs Market: Insufficient data to determine if A038460's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A038460's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A038460's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A038460's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A038460's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/20 08:42
End of Day Share Price
2026/06/19 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioSmart Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.